ArticleTrials2021

Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial.

Aziza Ajlan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.